- Published on:
Havana, Aug 12 (Prensa Latina) Cuba´s Center for State Control of medicines, Equipment and Medical Devices (CECMED) on Wednesday authorized the start of a phase-II clinical trial with the vaccine candidate CIGB2020, seeking to stimulate the immune response against acute respiratory infections.
